Market Scope

Trusted Partner of Industry and Medical Professionals for Market Data, Independent Perspective, & Objective Analysis

Latest Reports Latest News

Market Scope Methodology

A Multi-Step Approach for Accurate & Timely Data

Proprietary data

  • 20+ years of physician survey data
  • Disease models
  • Cultivated database of physicians, ASCs, and hospitals
  • Insight from our team of in-house industry experts

Public data

  • Attendance and participation at major, worldwide meetings
  • Public health systems and registries
  • Clinical study data
  • Analysis of company-published financial reports

Physician Surveys

For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.

Complete a Survey

On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.

Benchmark Your Performance

Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.

View Market Insights & Analytics

Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.

Learn More Register Today

Latest Market Reports

Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.

Latest Industry News & Trends

2/26/2021
BreakingPharmaRefractiveRegulation
Allergan Submits New Drug Application to US FDA for Presbyopia Drop
Allergan Submits New Drug Application to US FDA for Presbyopia Drop

Allergan, an AbbVie company, announced Feb. 25 that it had submitted a new drug application (NDA) to the US FDA for AGN-190584 (pilocarpine 1.25%) ophthalmic solution for symptoms of presbyopia. Th...

2/26/2021
BreakingCataractIOLRegulation
AcuFocus Submits US Premarket Approval Application for IC-8 Small Aperture IOL
AcuFocus Submits US Premarket Approval Application for IC-8 Small Aperture IOL

AcuFocus announced Feb. 23 that it had submitted a premarket approval (PMA) application to the US FDA for its IC-8 small aperture IOL. The IC-8 is an aspheric monofocal lens that features an embedd...

2/26/2021
BreakingCataractDry EyeEarningsRefractiveSurgical
2020 Earnings Roundup: Alcon, Bausch, Horizon, and Four More
2020 Earnings Roundup: Alcon, Bausch, Horizon, and Four More

Alcon reported Feb. 23 that full-year 2020 revenue totaled $6.8 billion, a decrease of 8 percent on a reported and constant currency basis, from $7.4 billion in 2019. The company said a substantial...

2/26/2021
BreakingGene TherapyRetina
Oculogenex Gene Therapy Startup Wins Winning Pitch Challenge—Retina
Oculogenex Gene Therapy Startup Wins Winning Pitch Challenge—Retina

Ophthalmologist Hema Ramkumar, MD, won the 2021 Winning Pitch Challenge—Retina, a virtual competition held Feb. 6. Ramkumar, a surgeon at Retina Consultants of Orange County, is the founder of Ocul...

2/26/2021
BreakingInstrumentsSurgical
Oertli Begins Construction of New Production and Logistics Factory
Oertli Begins Construction of New Production and Logistics Factory

Swiss ophthalmic surgical instrument maker Oertli announced Feb. 17 that it had started construction on a new factory at its location in Berneck. The three-story production and logistics building w...

2/26/2021
BreakingDry EyeSurgical
I-MED Pharma Shifts Surgical Portfolio to Keir to Focus on Dry Eye
I-MED Pharma Shifts Surgical Portfolio to Keir to Focus on Dry Eye

I-MED Pharma, of Montreal, Canada, announced Feb. 2 that Keir Surgical had taken ownership of its ophthalmic surgical portfolio. No financial details were given. I-MED said it would reinvest the pr...

2/26/2021
BreakingDealsGlaucomaPharma
UK’s Medicom Buys Generic Bimatoprost from Famar of Spain
UK’s Medicom Buys Generic Bimatoprost from Famar of Spain

Medicom Healthcare Limited, of the UK, announced Feb. 10 that it had acquired the product dossier of bimatoprost 0.3 mg/mL, 3ml, preservative-free eye drop solution from Spain’s Famar Health Care S...

2/26/2021
BreakingGene TherapyRetina
Ocugen Gene Therapy Candidate for RP, LCA Gains Orphan Status in EU
Ocugen Gene Therapy Candidate for RP, LCA Gains Orphan Status in EU

Ocugen announced Feb. 23that the European Commission had granted orphan medicinal product designation for its OCU400 gene therapy candidate for retinitis pigmentosa (RP) and Leber congenital amauro...

Join Market Scope Today

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more

Register A Clinical Account

A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.

United States
US Surveys
May select more than one

Market Scope

13421 Manchester Road, Suite 101 | St. Louis, MO 63131 | Phone: 314-835-0600 | Email: info@market-scope.com

©2021 Market Scope, LLC. All Rights reserved.